42 Results for "

ChoK

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "ChoK" in MCE Product Catalog:

47
47 Publications Verification
Cat. No.: HY-10451
CAS No.: 842133-18-0
Purity:  99.70%
Synonyms: JNJ 28431754
Target:  

SGLT

Research Areas:  

Metabolic Disease Cancer

Canagliflozin (JNJ 28431754) is a selective SGLT2 inhibitor with IC50s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively .
loading...
    loading...
47
47 Publications Verification
Cat. No.: HY-I0383
CAS No.: 928672-86-0
Synonyms: JNJ 28431754 hemihydrate
Target:  

SGLT

Research Areas:  

Metabolic Disease Cancer

Canagliflozin hemihydrate (JNJ28431754 hemihydrate) is a selective SGLT2 inhibitor with IC50s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-115463
CAS No.: 1839150-63-8
Purity:  99.57%
Target:  

AMPK Apoptosis

Research Areas:  

Cancer

EB-3D is a potent and selective choline kinase α (ChoKα) inhibitor, with an IC50 of 1 μM for ChoKα1. EB-3D exerts effects on ChoKα expression, AMPK activation, apoptosis, endoplasmic reticulum stress and lipid metabolism. EB-3D exhibits a potent antiproliferative activity in a panel of T-leukemia cell lines. Anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P990006
CAS No.: 2750005-84-4
Synonyms: TEV-48574; SAR-447189; TEV-574

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology Cancer

Duvakitug (TEV-48574) is a humanized IgG1-λ2 monoclonal antibody targeting to TNFSF15/TL1A. Duvakitug' main expression system is CHOK1SV cells endogenously expressing glutamine synthetase (GS). Duvakitug can be used in the study of Crohn's Disease (CD) .
loading...
    loading...
Cat. No.: HY-P4146
CAS No.: 2805997-46-8
Synonyms: BI 456906
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake .
loading...
    loading...
Cat. No.: HY-101144
CAS No.: 850807-63-5
Purity:  98.44%
Synonyms: TCD-717
Target:  

Choline Kinase

Research Areas:  

Cancer

RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles .
loading...
    loading...
Cat. No.: HY-108003
CAS No.: 1876450-21-3
Purity:  99.95%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

MM 07 is a biased apelin receptor agonist, with a KD of 300 nM in CHO-K1 cells and a KD of 172 nM in human heart.
loading...
    loading...
Cat. No.: HY-161247
CAS No.: 2641482-08-6
Target:  

5-HT Receptor

Research Areas:  

Metabolic Disease

5HT2A antagonist 2 is an orally active, selective antagonist for 5HT2A with IC50 of 14 nM. 5-HT2A antagonist 2 exhibits good chemical, hepatocyte, and plasma stability, without significant cytotoxicity in cell lines VERO, HFL-1, L929, NIH3T3, CHO-K1 .
loading...
    loading...
Cat. No.: HY-P99870
CAS No.: 2445460-16-0
Synonyms: ASLAN004; CSL-334; MK-6105

Target:  

Interleukin Related

Research Areas:  

Others

Eblasakimab (ASLAN004; CSL-334) is a human IgG4 antibody that specifically targets IL13RA1 and is primarily expressed by CHO-K1 cells .
loading...
    loading...
Cat. No.: HY-123335A
CAS No.: 2922280-21-3
Purity:  98.00%
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

L-796778 acetate is a selective agonist of the sst3 receptor. In CHO-K1 cells expressing the hsst3 receptor, L-796778 acetate is a partial agonist that inhibits Forskolin (HY-15371)-stimulated cAMP production with an IC50 value of 18 nM. L-796778 acetate has anticonvulsant effect .
loading...
    loading...
Cat. No.: HY-122140
CAS No.: 795316-16-4
Purity:  99.72%
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

ACG548B (compound 24) is a potent inhibitor of acetyl- and butyrylcholinesterase (AChE and BChE) with IC50s of 1.78 and 0.496 μM, respectively. ACG548B has higher AChE affinity and selectivity over BChE and ChoK (choline kinase). ACG548B can be uesd for the study of myasthenia gravis and neuromuscular blockade .
loading...
    loading...
Cat. No.: HY-P3789
CAS No.: 222988-10-5
Target:  

GnRH Receptor

Research Areas:  

Metabolic Disease

Prolactin-Releasing Peptide (12-31), rat is a fragment of the prolactin releasing peptide (PrRP). Prolactin-Releasing Peptide (12-31), rat shows high affinity for GPR10 receptors. Prolactin-Releasing Peptide (12-31), stimulates calcium mobilization in CHOK1 cells transfected with the PrRP receptor .
loading...
    loading...
Cat. No.: HY-136895
CAS No.: 945396-55-4
Purity:  98.44%
Research Areas:  

Cancer

AZ12672857 is an orally active inhibitor of EphB4 (IC50=1.3 nM) and Src kinases. AZ12672857 shows good inhibition of proliferation of c-Src transfected 3T3 cells (IC50=2 nM) as well as autophosphorylation of EphB4 in transfected CHO-K1 cells (IC50=9 nM) .
loading...
    loading...
Cat. No.: HY-132225
CAS No.: 158942-04-2
Purity:  99.35%
Target:  

5-HT Receptor

Research Areas:  

Inflammation/Immunology

SB 206553 is a 5-HT2C inverse agonist. SB 206553 can attenuate methamphetamine-seeking in rats. SB 206553 has activity for 5-HT2 receptor ligands in HEK-293 or CHO-K1 cells expressing human recombinant 5-HT2 receptors with pKi values of 5.6 nM (5-HT2A), 7.7 nM (5-HT2B) and 7.8 nM (5-HT2C), respectively. SB 206553 can be used for the research of psychostimulant abuse disorders .
loading...
    loading...
Cat. No.: HY-P99888
CAS No.: 2251771-76-1

Target:  

EGFR

Research Areas:  

Others

Pimurutamab is a humanized IgG1-κ antibody targeting EGFR. Mainly expressed by CHO-K1 cells .
loading...
    loading...
Cat. No.: HY-123335
CAS No.: 217480-25-6
Target:  

Somatostatin Receptor

Research Areas:  

Others

L-796778 is an agonist of the hsst3 receptor. In CHO-K1 cells expressing the hsst3 receptor, L-796778 is a partial agonist that inhibits forskolin (HY-15371)-stimulated cAMP production with an IC50 value of 18 nM .
loading...
    loading...
Cat. No.: HY-117617
CAS No.: 1243583-88-1
Research Areas:  

Cancer

CAY10669 (compound 6d) is an anacardic acid (HY-N2020) derivative that inhibits histone acetyltransferase PCAF with an IC50 of 662 μM . CAY10669 enhances the SAHA-induced acetylation in HEPG2 cells, exhibits cytotoxicity in zebrafish embryo, promotes transgene expression in CHO-K1 cells .
loading...
    loading...
Cat. No.: HY-P991114
CAS No.: 2921564-55-6

Target:  

FLT3

Research Areas:  

Inflammation/Immunology

Adezkibart is a human monoclonal antibody immunosuppressant targeting the human FMS-like tyrosine kinase 3 ligand (FLT3LG). Adezkibart is found in the Chinese hamster ovary cell line CHO-K1, which binds to FLT3LG to block the relevant signaling pathway, inhibits the immune response, and exerts immunosuppressive activity. Adezkibart is promising for research of immune-related diseases .
loading...
    loading...
Cat. No.: HY-122675
CAS No.: 795316-15-3
Purity:  98.99%
Target:  

Choline Kinase

Research Areas:  

Cancer

ACG416B (compound 18) is a potent inhibitor of ChoK (choline kinase) with an IC50 of 0.4 μM. ACG416B renders higher ChoK inhibitory and antiproliferative activities against the HT-29 human colon cancer cell .
loading...
    loading...
Cat. No.: HY-P4146A
Synonyms: BI 456906 TFA
Target:  

GLP Receptor GCGR

Research Areas:  

Metabolic Disease

Survodutide (BI 456906) TFA is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide TFA, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide TFA has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake .
loading...
    loading...